John Snow Labs Awarded Phase I SBIR Contract for the Development of Medical Large Language Models for Infectious and Immune-Mediated Diseases
17 sept. 2024 09h00 HE
|
John Snow Labs
John Snow Labs has been awarded an SBIR Phase I contract from NIAID for the development of medical LLMs for infectious and immune-mediated diseases.
Radiofrequency Ablation Device Market Global Forecast Report 2024-2032: Surge in Demand for Non-Invasive Surgeries, Technological Advancements Boost Precision and Safety
09 sept. 2024 10h17 HE
|
Research and Markets
Dublin, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The "Radiofrequency Ablation Device Market Global Forecast Report by Product Application End Users Countries and Company Analysis, 2024-2032" report has...
Intelligent Bio Solutions Inc. Announces Preliminary Full Fiscal Year 2024 Revenue Growth of 148% Year-Over-Year
09 sept. 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
- 2024 unaudited revenue growth for the fiscal fourth quarter and full year of approximately 64% and 148% year-over-year, respectively - NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Intelligent...
Intelligent Bio Solutions Inc. Reports 118% Year-Over-Year Growth in Customer Employee Base, Reaching an Estimated Total of 1.4 Million Employees
03 sept. 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the “Company”), a leader in non-invasive drug testing technology, today announced significant...
Intelligent Bio Solutions Inc. Achieves Major Milestone with Over 1,000 Installed Intelligent Fingerprinting Drug Screening Readers as of June 30, 2024
21 août 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the “Company”), a leading innovator in non-invasive drug testing technology, today announced the...
Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update
20 août 2024 08h00 HE
|
Nano-X Imaging LTD.
Nanox Announces Second Quarter of 2024 Financial Results and
Provides Business Update
Medical Tubing Market Surges to USD 16.77 Billion by 2031, Propelled by 8.01% CAGR - Verified Market Research®
07 août 2024 10h00 HE
|
Verified Market Research
Lewes, Delaware, Aug. 07, 2024 (GLOBE NEWSWIRE) -- The Global Medical Tubing Market Size is projected to grow at a CAGR of 8.01% from 2024 to 2031, according to a new report published by Verified...
Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway
01 août 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
Intelligent Bio Solutions Inc. (INBS) partners with CenExel to perform a method comparison clinical study as part of the Company’s FDA clinical study plan.
Intelligent Bio Solutions Inc. Announces QabasTech as Exclusive Distributor in Saudi Arabia
24 juil. 2024 08h30 HE
|
Intelligent Bio Solutions, Inc.
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...
Japan Medical Implant Market Poised for Significant Growth, Exceeding USD 3.5 Billion by 2023: Demographic Trends Supporting Market Development, Competitive Landscape and Strategic Collaborations
24 juil. 2024 06h40 HE
|
Research and Markets
Dublin, July 24, 2024 (GLOBE NEWSWIRE) -- The "Japan Medical Implant Market Overview, 2029" report has been added to ResearchAndMarkets.com's offering.The Japanese market for medical implants is...